 |
14 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- IDX21459 / Merck (MSD)
Enrollment change, Trial termination: Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects (clinicaltrials.gov) - Aug 29, 2014
P1, N=48, Terminated, Sponsor: Idenix Pharmaceuticals
N=91 --> 48 | Recruiting --> Terminated; Early termination of IDX21459 was due to integration of Merck's HCV antiviral pipeline has resulted in revisions of the clinical development plan.
- ||| IDX21459 / Merck (MSD)
New P1 trial: Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects (clinicaltrials.gov) - Apr 10, 2014
P1, N=91, Recruiting, Sponsor: Idenix Pharmaceuticals